From the first dose to your follow-ups, you'll have the support you need to feel confident in your weight loss plan
doi: 10.3389/fendo.2020.00474 Received 09 March 2020 Accepted 16 June 2020 Published 28 July 2020 Volume 11 - 2020 Edited by Erwin Dieter Schleicher, University of Tbingen, Germany Reviewed by Hans Ulrich Hring, Tbingen University Hospital, Germany
Semaglutide promotes weight reduction by suppressing appetite and slowing gastric emptying
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context for GLP-1 response variability by assessing predispositions in key appetite and glucose-regulation pathways
Patients should avoid injecting into areas with bruising, scars, lipodystrophy, or inflamed skin
Just as combining different treatments is common for managing these conditions, it might seem logical to combine weight-loss medications for better results